Refractory Anemia With Excess Blasts in Transformation
Also known as: Refractory anemia with excess blasts in transformation / Acute myeloblastic leukemia, minimal differentiation / Refractory anaemia with excess blasts in transformation / Myelodysplastic syndrome transformation
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00928 | Azacitidine | A pyrimidine nucleoside analogue used to treat certain subtypes of myelodysplastic syndrome. |
| DB01262 | Decitabine | A chemotherapeutic agent used for the treatment of myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, and conditions related to refractory anemia. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00928 | Azacitidine | DNA (cytosine-5)-methyltransferase 1 | target |
| DB00928 | Azacitidine | Cytidine deaminase | enzyme |
| DB00928 | Azacitidine | DNA | target |
| DB00928 | Azacitidine | RNA | target |
| DB01262 | Decitabine | DNA | target |
| DB01262 | Decitabine | DNA (cytosine-5)-methyltransferase 1 | target |
| DB01262 | Decitabine | Deoxycytidine kinase | enzyme |